Alan Wells, MD, DMSc
Thomas J. Gill III Professor of Pathology

Alan Wells, MD, DMSc, is the Vice-Chairman and Head of the Section of Laboratory Medicine (encompassing Clinical Chemistry, Clinical Microbiology, Hematopathology, Immunopathology, Molecular Diagnostics, and Transfusion Medicine). He also serves as the Medical Director for the UPMC Clinical Laboratories. As the Thomas Gill III Professor of Pathology, Wells directs a large research endeavor investigation how cells interact with and respond to their microenvironment during cancer dissemination and wound healing, with an eye towards biologically engineered and stem cell therapeutics in these arenas.

Office Location:
UPMC Clinical Laboratories
UPMC Clinical Lab Building-Rm. 9022
3477 Euler Way
Pittsburgh, PA 15213 USA
Contact Information:
Office Telephone: 412-647-7813
Fax: 412-647-8567

Clinical Experties

Alan Wells, MD DMSc, is medical director of the largest integrated academically-based clinical laboratory enterprise in the US. His clinical expertise resides in clinical laboratory medical management and how that impacts quality care.

Research Interests

" Within his laboratory, Dr. Wells and his research team are aiming to gain a better understanding of cells respond to their local environment. Due to the widespread implications of such research, Dr. Wells has been featured in several publications. Ultimately, the importance of his research flows from the provision of reinforcing insights and novel avenues for exploration into the basic signaling pathways, as well as functioning of entire organisms. Currently, Dr. Wells is concentrating his research efforts towards gaining further knowledge of the conditions of dysregulated (tumor dissemination and chemoresistance of tumors) and orchestrated (wound healing and organogenesis) responses.

Awards and Honors

  • 2001 - American Society for Clinical Investigation
  • 2002 - American Association of University Pathologists (Pluto Club)
  • 2008 - Keynote Speaker, European Tissue Repair Society Annual Meeting, Malta
  • 2008 - Pitt Innovator Awardee
  • 2010 -11 Chair, NIH Study Section Surgery, Anesthesiology and Trauma (SAT)
  • 2011 - William E Brown Outstanding MSTP Mentor Award, UPitt
  • 2011 - Distinguished Mentor, Biomedical Graduate Students Association, UPitt
  • 2011 - Keynote Speaker, Japan Society for Laboratory Medicine Annual Meeting
  • 2012 - Keynote Speaker, WVU Breast Cancer Center, Annual Retreat, West Virginia Univ
  • 2012 - Gregory Derringer Pathology Grand Round, IUPUI
  • 2012 - Chair, VA Study Section - Oncology
  • 2013 - Provost's Award for Excellence in Mentoring, UPitt
  • 2013 - Pitt Innovator Awardee

Selected Publications

View Dr. Wells' publications on PubMed

YL Chao, Q Wu, C Shepard, A Wells (2012). Hepatocyte-induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance. Clinical and Experimental Metastasis 29, 39-50. PMID: 21964676.

C Yates, DL Whaley, A Wells (2012). Transplanted fibroblasts prevent dysfunctional repair in a murine CXCR3-deficient scarring model. Cell Transplantation 21, 919-931. PMID: 22236446

YL Chao, Q Wu, M Acquafondata, R Dhir, A Wells (2012). Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases. Cancer Microenvironment 5, 19-28. PMID: 21892699. PMC3343195

M Rodrigues, O Turner, D Stolz, L Griffith, A Wells (2012). Production of reactive oxygen species by multipotent stromal cells/mesenchymal stem cells upon exposure to Fas Ligand. Cell Transplantation 21, 2171-2187. PMID: 22526333

Q Wu, R Dhir, A Wells (2012). Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion. Molecular Cancer 11, 3e. PMID: 22236567. PMC3320557.

AS Meyer, SK Hughes-Alford, JE Kay, A Castillo, A Wells, FB Gertler, DA Lauffenburger (2012). 2D Protrusion but not motility predicts growth factor-induced cancer cell migration in 3D collagen. Journal of Cell Biology 197, 721-729. PMID: 22665521. PMC3373410

C Yates-Binder, M Rodger, J Jaynes, A Wells, RJ Bodnar, T Turner (2012). An IP-10 (CXCL10)-derived peptide inhibits angiogenesis. PLoS One, e40812. PMID: 22815829

J Jones, H Wang, J Zhou, S Hardy, T Turner, D Austin, Q He, A Wells, W Grizzle, C Yates (2012). Nuclear Kaiso indicates aggressive prostate cancer and promotes migration and invasiveness of prostate cancer cells. American Journal of Pathology 181, 1836-1846. PMID: 22974583

J Grahovac, D Becker, A Wells (2013). Melanoma cell invasiveness is regulated at least in part by the epidermal growth factor-like repeats of tenascin-C. Journal of Investigative Dermatology 133, 210-220. PMID: 22951722

M Rodrigues, HC Blair, L Stockdale, L Griffith, A Wells (2013). Surface tethered epidermal growth factor protects proliferating and differentiating multipotent stromal cells from FasL induced apoptosis. Stem Cells 31, 104-116. PMID: 22948863

T Travers, H Shao, A Wells, C Camacho (2013). Modeling the assembly and disassembly of multi-domain structures of -actinin-4 and its role in actin-crosslinking. Biophysical Journal 104, 705-715. PMID: 23442921

D Taylor, JZ Wells, A Savol, C Chennubhotla, A Wells (2013). Modeling boundary conditions for balanced proliferation in metastatic latency. Clinical Cancer Research 19, 1063-1070. PMID: 23329811. PMC3594128

H Shao, T Travers, C Camacho, A Wells (2013). The carboxyl tail of alpha-actinin-4 regulates its susceptibility to m-calpain and thus functions in cell migration and spreading. International Journal of Biochemistry and Cell Biology 45, 1051-1063.

M Rodrigues, CC Yates, A Nuschke, L Griffith, A Wells (2013). The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL. Tissue Engineering 19, 1972-1983. PMID: 23541003; PMC: 3725854

Z Ding, M Joy, R Bhargava, M Gunsaulus, N Lakshman, M Miron-Mendoza, M Petroll, J Condeelis, A Wells, P Roy (2013) Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis. Oncogene, in press. PMID: 23686314. PMCID: PMC3834125

J Jamison, D Lauffenburger, JH-C Wang, A Wells (2013). PKCδ localization at the membrane increases traction force dependent on PLC?1/EGFR signaling. PLoS One 8, e77434. PMID: 24155954. PMC3796482

T-C Hang, NC Tedford, RJ Reddy, T Rimchala, A Wells, FM White, RD Kamm, DA Lauffenburger (2013). Vascular endothelial growth factor and platelet factor 4 inputs modulate human microvascular endothelial signaling in a three-dimensional matrix migration context. Molecular and Cellular Proteomics 12, 3704-3718. PMID: 24023389. PMC3861718

RJ Bodnar, ME Rodgers, W Chen, A Wells (2013). Pericyte regulation of vascular remodeling through the CXC Receptor 3. Arteriosclerosis, Thrombosis, and Vascular Biology 33, 2818-2829. PMID: 24135023

MC Sekar, K Shahiwala, L Leloup, A Wells (2014). Modulation of epidermal growth factor stimulated ERK phosphorylation and motility by inositol trisphosphate kinase. Journal of Pharmacological Sciences and Pharmacology 1, 1-5.

DP Taylor, A Clark, S Wheeler, A Wells (2014). Hepatic nonparenchymal cells drive metastatic breast cancer outgrowth and partial epithelial to mesenchymal transition. Breast Cancer Research and Treatment 144, 551-560. PMID: 24610032

B Ma, A Wells (2014). The MAP kinases p38 and ERK are involved in hepatocyte-mediated phenotypic switching in prostate cancer cells. Journal of Biological Chemistry 289, 11153-11161. PMID: 24619413

J Jamison, JH-C Wang, A Wells (2014). PKC regulates force signaling during VEGF/CXCL4 induced dissociation of endothelial tubes. PLoS One 9, e93968. PMID: 24699667, PMCID: PMC3974837


M Rodrigues, LG Griffith, A Wells (2012). Adult stem cell survival strategies. In Biomaterials and Stem Cells in Regenerative Medicine (Eds: M Ramalingam, S Ramkrishna, S Best; CRC Press).

NPAD Gunasinghe, A Wells, EW Thompson, HJ Hugo (2012). Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer Metastasis Reviews 31, 469-478. PMID: 22729277

A Wells (2012). Laboratory Medicine: A view to the future of diagnostics and training. Special lecture of the 58th National Congress (Japan). Rinsho Byori - the Japanese Journal of Clinical Pathology 60, 312-320. PMID: 22686040

S Park, L Pantanowitz, AV Parwani, A Wells, ZN Oltvai (2012). Workflow organization in pathology. Clinics in Laboratory Medicine 32, 601-622.

CC Yates, P Hebda, A Wells (2012). Skin wound healing and scarring: fetal wounds and regenerative restitution. BDRC - Embryo Today 96, 325-333.

AC Huen, A Wells (2012). The beginning of the end: CXCR3 signaling in late-stage wound healing. Advances in Wound Care 1, 244-248.

A Wells, J Grahovac, S Wheeler, DP Taylor, B Ma, DA Lauffenburger (2013). Targeting tumor cell motility as a strategy against invasion and metastasis. Trends in Pharmaceutical Sciences 34, 283-289. PMID: 23571046. PMC3640670

A Wells, LG Griffith, JZ Wells, DP Taylor (2013). The dormancy dilemna: Balanced proliferation versus quiescence. Cancer Research 73, 3811-3816. PMID: 23794703. PMC3702639

J Grahovac, DA Lauffenburger, A Wells (2014). Matricellular proteins as regulators of cancer cell invasion. Lab Investigation 94, 31-40. PMID: 24247562.

SE Wheeler, (alphabetically): JT Borenstein, AM Clark, M Ebrahimkhani, IJ Fox, L Griffith, W Inman, D Lauffenburger, T Nguyen, VC Pillai, R Prantil-Baun, DB Stolz, D Taylor, T Ulrich, R Venkataramanan, A Wells, C Young (2014). All-Human Model of Metastasis Therapy. Stem Cell Research and Therapy 4S1, S11. PMID: 24565274. PMC in process

AM Clark, SE Wheeler, DP Taylor, VC Pillai, CL Young, R Prantil-Baun, T Nguyen, DB Stolz, JT Borenstein, DA Lauffenburger, R Venkataramanan, LG Griffith, A Wells (2014). A microphysiological system model of therapy for liver micrometastases. Experimental Biology and Medicine, in press. PMID: 24821820. PMC in process after embargo

LG Griffith, A Wells, DB Stolz (2014). Engineering liver. Hepatology, in press.